HomeInsightsMarket Capitalization

Market Capitalization of Divis Laboratories Ltd

Market Capitalization of Divis Laboratories Ltd

stocks purchased

₹ 6.2 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

10.5 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Divis Laboratories Ltd

NSE: DIVISLAB

Market Cap

₹ 155159.75 crore

Last updated on: Dec 20, 2024

Key Highlights

  • The Market Cap of Divis Laboratories Ltd is ₹ 155159 crore as of 20 Dec 24 .
  • The Market Cap of Divis Laboratories Ltd changed from ₹ 45214 crore on March 2019 to ₹ 91234 crore on March 2024 . This represents a CAGR of 12.41% over 6 years.
  • The Latest Trading Price of Divis Laboratories Ltd is ₹ 5844 as of 20 Dec 15:30 .
  • The Dividend Payouts of Divis Laboratories Ltd changed from ₹ 16 on Aug 14, 2019 to ₹ 30 on Aug 02, 2024 . This represents a CAGR of 11.05% over 6 years.

Historical Market Cap of Divis Laboratories Ltd

No data available

* All values are in crore

Company Fundamentals for Divis Laboratories Ltd

No data available

Image

Divis Laboratories Ltd

NSE: DIVISLAB

Share Price

₹ 5844.75

23.15 (0.40%)

stock direction

Last updated on: Dec 20, 2024

Market Price of Divis Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Divis Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 20245844.75
19 Dec 20245821.6
18 Dec 20245848.2
17 Dec 20245849.05
16 Dec 20245852.4
13 Dec 20245876.2
12 Dec 20245946.95
11 Dec 20245932.5
10 Dec 20245931.55
09 Dec 20245959.75

SWOT Analysis Of Divis Laboratories Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Divis Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Divis Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Divis Laboratories Ltd

No data available

No data available

Historical P/E Ratio of Divis Laboratories Ltd

No data available

* All values are in %

Historical Revenue of Divis Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Divis Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Divis Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Divis Laboratories Ltd

No data available

* All values are in

About Divis Laboratories Ltd

  • Divi's Laboratories Ltd. is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals.
  • The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries.
  • It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
  • In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
  • It is among the largest pharmaceutical companies in India with a portfolio of approx.

Divis Laboratories Ltd News Hub

News

Divis Laboratories Ltd spurts 1.29%, gains for five straight sessions

Divis Laboratories Ltd rose for a fifth straight session today. The stock is quoting at Rs...

Read more

25 Nov 2024 13:00

News

Divi's Labs PAT soars 47% YoY to Rs 510 crore in Q2

Total income grew by 22.51% year on year (YoY) to Rs 2,444 crore in the quarter ended 30 S...

Read more

09 Nov 2024 16:09

News

Divis Laboratories declare Quarterly Result

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 9 Novem...

Read more

30 Oct 2024 14:53

News

Divis Laboratories Ltd slips for fifth straight session

Divis Laboratories Ltd dropped for a fifth straight session today. The stock is quoting at...

Read more

23 Oct 2024 13:35

News

CARE Ratings reaffirms ratings of Divi's Labs with 'stable' outlook

The agency has also affirmed the company's short term rating at 'CARE A1+'. CARE Ratings s...

Read more

16 Sep 2024 12:01

News

Divis Laboratories receives affirmation in credit ratings for bank facilities

Divis Laboratories has received reaffirmation in credit ratings for bank facilities aggreg...

Read more

14 Sep 2024 15:10

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Divis Laboratories Ltd Market Cap

What is the market cap of Divis Laboratories Ltd?

As of December 22, 2024, Divis Laboratories Ltd has a market capitalization of ₹155159.75, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Divis Laboratories Ltd's market capitalization?

Divis Laboratories Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Divis Laboratories Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Divis Laboratories Ltd's market capitalization change?

Divis Laboratories Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions